Breaking News Instant updates and real-time market news.

NH

NantHealth

$12.79

-0.05 (-0.39%)

04:55
10/17/16
10/17
04:55
10/17/16
04:55

NantHealth management to meet with Jefferies

Meeting to be held in New York on October 17 hosted by Jefferies.

  • 17

    Oct

  • 17

    Nov

NH NantHealth
$12.79

-0.05 (-0.39%)

06/27/16
COWN
06/27/16
INITIATION
Target $19
COWN
Outperform
NantHealth initiated with an Outperform at Cowen
Cowen analyst Charles Rhyee started NantHealth with an Outperform rating and $19 price target.
06/27/16
FANA
06/27/16
INITIATION
Target $18
FANA
Overweight
NantHealth initiated with an Overweight at First Analysis
First Analysis analyst Joseph Munda started NantHealth with an Overweight rating and $18 price target, saying he believes the company has assembled a powerful combination of information technology and advanced molecular diagnostics and views its leadership as exceptionally well qualified.
06/27/16
ADAM
06/27/16
INITIATION
Target $17
ADAM
Buy
NantHealth initiated with a Buy at Canaccord
Canaccord analyst Richard Close initiated NantHealth with a Buy and $17 price target following its recent IPO. The firm sees NantHealth as a leader in precision medicine, bringing to market an innovative cancer diagnostic test coupled with a cloud-based offering to drive increased value.
06/27/16
06/27/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on the today's top five analyst initiations with this list compiled by The Fly: 1. Spectra Energy (SE) initiated with an Outperform at RBC Capital by analyst Elvira Scotto, who has a $39 price target on the stock. The analyst believes Spectra can deliver solid, highly visible cash-flow and dividend growth over the next several years underpinned by a robust backlog of demand-pull growth projects. 2. GW Pharmaceuticals (GWPH) initiated with a Sell at Janney Capital by analyst Ken Trbovich, who has a $40 price target on the stock. The analyst said GW awaits imminent results of Phase 3 trial results in Lennox-Gastaut Syndrome. Unfortunately, even if the data in LGS is good, Trbovich thinks its valuation exceeds the commercial prospects for drugs that treat orphan epilepsy indications.3. NantHealth (NH) initiated with a Buy at Canaccord by analyst Richard Close, who has a $17 price target following its recent IPO. The firm sees NantHealth as a leader in precision medicine, bringing to market an innovative cancer diagnostic test coupled with a cloud-based offering to drive increased value. NantHealth was also initiated with an Outperform at FBR Capital and Cowen and an Ovweight at First Analysis, with analyst Joseph Munda saying he believes the company has assembled a powerful combination of information technology and advanced molecular diagnostics and views its leadership as exceptionally well qualified. 4. Skyworks (SWKS) initiated with an Underweight at Morgan Stanley by analysts led by Craig Hettenbach, who put a $61 price target on the stock. The analyst said Skyworks is far behind Broadcom on business diversification and customer concentration will likely pressure the stock's multiple. 5. Clearside Biomedical (CLSD) initiated with an Outperform at Cowen by analyst Boris Peaker, who noted the company is developing a novel device that enables the administration of drugs to the back of the eye with minimal front of the eye exposure which can be used for indications like AMD, DME, and glaucoma. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

DUST

Direxion Daily Gold Miners Bear 3X ETF

$20.92

-1.1 (-5.00%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Technical Analysis
Direxion Daily Gold Miners Bear 3X ETF: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CEVA

Ceva

$48.35

0.05 (0.10%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Downgrade
Ceva rating change  »

Ceva downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Feb

JDST

Direxion Daily Junior Gold Miners Index Bear 3x Shares

$46.38

-2.19 (-4.51%)

06:58
01/24/18
01/24
06:58
01/24/18
06:58
Technical Analysis
Daily Junior Gold Miners Index Bear 3x Shares: Pivot points, pivot low broken »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SGMS

Scientific Games

$54.85

-1 (-1.79%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Earnings
Scientific Games sees Q4 revenue $820M-$825M, consensus $802.58M »

Scientific Games further…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VXX

iPath S&P 500 VIX Short-Term Futures

$26.69

0.44 (1.68%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Technical Analysis
iPath S&P 500 VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WTFC

Wintrust Financial

$88.04

0.54 (0.62%)

06:57
01/24/18
01/24
06:57
01/24/18
06:57
Recommendations
Wintrust Financial analyst commentary  »

Wintrust Financial price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$12.94

0.29 (2.29%)

, MU

Micron

$43.95

1.07 (2.50%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Periodicals
AMD taps former Nvidia, Synaptics execs for graphics chip division, VB reports »

Advanced Micro Devices…

AMD

AMD

$12.94

0.29 (2.29%)

MU

Micron

$43.95

1.07 (2.50%)

NVDA

Nvidia

$238.91

5.22 (2.23%)

SYNA

Synaptics

$44.90

-0.45 (-0.99%)

INTC

Intel

$46.06

0.31 (0.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 25

    Jan

  • 30

    Jan

  • 07

    Feb

  • 26

    Mar

XIV

VelocityShares Daily Inverse VIX Short-Term ETN

$141.82

-2.88 (-1.99%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Technical Analysis
VelocityShares Daily Inverse VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TVIX

VelocityShares Daily 2x VIX Short-Term ETN

$5.05

0.17 (3.48%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Technical Analysis
VelocityShares Daily 2x VIX Short-Term ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IMMU

Immunomedics

$18.11

0.96 (5.60%)

06:56
01/24/18
01/24
06:56
01/24/18
06:56
Recommendations
Immunomedics analyst commentary  »

Immunomedics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SVXY

ProShares Short VIX Short-Term Futures

$133.48

-2.44 (-1.80%)

06:55
01/24/18
01/24
06:55
01/24/18
06:55
Technical Analysis
ProShares Short VIX Short-Term Futures: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.97

0.19 (1.49%)

06:55
01/24/18
01/24
06:55
01/24/18
06:55
Technical Analysis
United States Oil Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XOP

SPDR Oil Exploration and Production Fund

$39.85

0.16 (0.40%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Technical Analysis
SPDR Oil Exploration and Production Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CWST

Casella Waste

$24.26

0.09 (0.37%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Upgrade
Casella Waste rating change  »

Casella Waste upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DGAZ

VelocityShares 3x Inv Natural Gas ETN

$20.44

-2.99 (-12.76%)

06:54
01/24/18
01/24
06:54
01/24/18
06:54
Technical Analysis
VelocityShares 3x Inv Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UGAZ

VelocityShares 3x Long Natural Gas ETN

$89.75

10.55 (13.32%)

06:53
01/24/18
01/24
06:53
01/24/18
06:53
Technical Analysis
VelocityShares 3x Long Natural Gas ETN: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWZ

MSCI Brazil Index

$43.66

-0.97 (-2.17%)

06:52
01/24/18
01/24
06:52
01/24/18
06:52
Technical Analysis
MSCI Brazil Index: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EFA

iShares MSCI EAFE Index Fund

$74.75

0.24 (0.32%)

06:51
01/24/18
01/24
06:51
01/24/18
06:51
Technical Analysis
iShares MSCI EAFE Index Fund: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USAP

Universal Stainless & Alloy

$22.85

0.44 (1.96%)

06:51
01/24/18
01/24
06:51
01/24/18
06:51
Earnings
Universal Stainless & Alloy reports Q4 EPS $1.06 with items vs. (22c) a year ago »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RES

RPC, Inc.

$25.13

-0.28 (-1.10%)

06:50
01/24/18
01/24
06:50
01/24/18
06:50
Hot Stocks
RPC, Inc. raises quarterly dividend by 43% to 10c per share »

The dividend is payable…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    May

BHGE

Baker Hughes

$35.82

0.27 (0.76%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Hot Stocks
Baker Hughes CEO: Continue to see improvement in activity »

Lorenzo Simonelli, BHGE…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RES

RPC, Inc.

$25.13

-0.28 (-1.10%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Earnings
RPC, Inc. reports Q4 adjusted EPS 27c, consensus 34c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 15

    May

PBYI

Puma Biotechnology

$90.90

-3.05 (-3.25%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Downgrade
Puma Biotechnology rating change  »

Cowen downgrades Puma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JNK

SPDR Barclays High Yield Bond

$36.96

0.11 (0.30%)

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Technical Analysis
SPDR Barclays High Yield Bond: Pivot points »

The following are the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZO

MarineMax

06:49
01/24/18
01/24
06:49
01/24/18
06:49
Earnings
Breaking Earnings news story on MarineMax »

MarineMax raises FY18 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.